Cargando…

Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis

BACKGROUND: Identifying Plasmodium vivax antigen-specific antibodies associated with P. vivax infection and protective immunity is key to the development of serosurveillance tools and vaccines for malaria. Antibody targets of P. vivax can be identified by seroepidemiological studies of individuals l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cutts, Julia C, Powell, Rosanna, Agius, Paul A, Beeson, James G, Simpson, Julie A, Fowkes, Freya J I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172944/ https://www.ncbi.nlm.nih.gov/pubmed/25199532 http://dx.doi.org/10.1186/s12916-014-0150-1

Ejemplares similares

Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum
por: McLean, Alistair R. D., et al.
Publicado: (2017)

Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting
por: Charnaud, Sarah C., et al.
Publicado: (2016)

Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review
por: Cutts, Julia C., et al.
Publicado: (2020)

Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period
por: McLean, Alistair R. D., et al.
Publicado: (2016)

The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis
por: Fowkes, Freya J. I., et al.
Publicado: (2010)

Anopheles salivary antigens as serological biomarkers of vector exposure and malaria transmission: A systematic review with multilevel modelling
por: Kearney, Ellen A, et al.
Publicado: (2021)

Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates
por: Chan, Jo-Anne, et al.
Publicado: (2014)

Towards a Vaccine against Plasmodium vivax Malaria
por: Beeson, James G, et al.
Publicado: (2007)

Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines
por: Fowkes, Freya JI, et al.
Publicado: (2013)

Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate–high malaria transmission intensity
por: Tayipto, Yanie, et al.
Publicado: (2022)

Understanding the interactions between iron supplementation, infectious disease and adverse birth outcomes is essential to guide public health recommendations
por: Fowkes, Freya J. I., et al.
Publicado: (2019)

Plasmodium vivax Adherence to Placental Glycosaminoglycans
por: Chotivanich, Kesinee, et al.
Publicado: (2012)

Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes
por: Maneerattanasak, Sarunya, et al.
Publicado: (2017)

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis
por: Commons, Robert J, et al.
Publicado: (2019)

Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis
por: Commons, Robert J., et al.
Publicado: (2020)

Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study
por: Ataíde, Ricardo, et al.
Publicado: (2017)

Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum
por: McCallum, Fiona J., et al.
Publicado: (2008)

Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi
por: Longley, Rhea J., et al.
Publicado: (2022)

Identification of Protein Markers in Patients Infected with Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax
por: Mu, Alan Kang-Wai, et al.
Publicado: (2014)

Serologic Markers in Relation to Parasite Exposure History Help to Estimate Transmission Dynamics of Plasmodium vivax
por: Yildiz Zeyrek, Fadile, et al.
Publicado: (2011)

Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts
por: Rosado, Jason, et al.
Publicado: (2021)

Immunity as a predictor of anti-malarial treatment failure: a systematic review
por: O’Flaherty, Katherine, et al.
Publicado: (2017)

Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
por: de Jong, Roos M., et al.
Publicado: (2019)

Plasmodium vivax Malaria
por: Kochar, Dhanpat K., et al.
Publicado: (2005)

Attacking Plasmodium vivax
por: Baird, J. Kevin
Publicado: (2016)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Networking the host immune response in Plasmodium vivax malaria
por: Mendonça, Vitor RR, et al.
Publicado: (2013)

Immune response pattern in recurrent Plasmodium vivax malaria
por: Chaves, Yury Oliveira, et al.
Publicado: (2016)

Evaluation of the effectiveness of topical repellent distributed by village health volunteer networks against Plasmodium spp. infection in Myanmar: A stepped-wedge cluster randomised trial
por: Agius, Paul A., et al.
Publicado: (2020)

Application of 23 Novel Serological Markers for Identifying Recent Exposure to Plasmodium vivax Parasites in an Endemic Population of Western Thailand
por: Chotirat, Sadudee, et al.
Publicado: (2021)

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure
por: Kurtovic, Liriye, et al.
Publicado: (2019)

A systematic analysis of the human immune response to Plasmodium vivax
por: Bach, Florian A., et al.
Publicado: (2023)

The anaemia of Plasmodium vivax malaria
por: Douglas, Nicholas M, et al.
Publicado: (2012)

Plasmodium vivax Mimicking Morphologic Features of Plasmodium falciparum
por: Ghanchi, Najia, et al.
Publicado: (2020)

Plasmodium vivax Transmission in Africa
por: Howes, Rosalind E., et al.
Publicado: (2015)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
por: Watson, James A, et al.
Publicado: (2022)

A review of malaria molecular markers for drug resistance in Plasmodium falciparum and Plasmodium vivax in China
por: Wang, Siqi, et al.
Publicado: (2023)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
por: Kenangalem, Enny, et al.
Publicado: (2016)

Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
por: Andrade, Bruno Bezerril, et al.
Publicado: (2009)

High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia
por: Kho, Steven, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7rmcikqlasr0ad094854nl8v8q